Companies/Variables

Companies Outputs

Johnson and Johnson  

Merck Total Revenue

Celgene Gross Profit

Forest Lab Inc Net Income

Alpharma Working Capital

Wyeth Total Assets

Endo  

ViroPharma Inputs

Watson Pharma  

Barr Pharma Cost of Sales

Mylan Lab. R&D expenditures

Eli Lilly Co Selling, gen.& admin op. exp.

Bristol Myer Squibb Capital Expenditures

Abbot Laboratories Employees

Allgerean Total Current Liabilities

Amgen Inc.  

Gilead Sciences, Inc.  

First Horizon  

Abbott Laboratories

Cost of Sales

Revenue

275000025000002250000200000017500001500000

6000000

5500000

5000000

4500000

4000000

3500000

S 171486R-Sq 91.1%R-Sq(adj) 90.3%

Regression95% CI

Abbott Laboratories Revenue = 1171910 + 1.643 COS

Abbott LaboratoriesForecast

Forecast/ COS

Re

ve

nu

e

60000005500000500000045000004000000

6000000

5500000

5000000

4500000

4000000

3500000

S 171486R-Sq 91.1%R-Sq(adj) 90.3%

Regression95% CI

Abbott LaboratoriesRevenue = 231 + 0.9998 Forecast

Revenue COS Forecast

4580463 2197741 4782798

4723635 2270855 4902925

4845881 2346807 5027714

5530582 2658013 5539025

5216053 2480281 5247012

4127851 1661863 3902351

4681669 2114919 4646722

5654443 2627094 5488225

5382679 2522531 5316428

5523800 2631835 5496015

5383995 2677188 5570530

6047334 2809557 5788012

Eli Lilly Co.

gross profit

tota

l/net

revenue

3000

000

2900

000

2800

000

2700

000

2600

000

2500

000

2400

000

2300

000

2200

000

4000000

3750000

3500000

3250000

3000000

S 56301.0R-Sq 96.4%R-Sq(adj) 96.0%

Regression95% CI

Eli Lilly Co.total/net revenue = - 256664 + 1.393 gross profit

Eli Lilly Co. Forecast

Forecast/ Gross Profit

Re

ve

nu

e

400000038000003600000340000032000003000000

4000000

3750000

3500000

3250000

3000000

S 56301.0R-Sq 96.4%

R-Sq(adj) 96.0%

Regression95% CI

Eli Lilly Co.total/net revenue = - 57 + 0.9998 Forecast

Revenue gross profit Forecast

2889400 2268100 2902799

3088200 2445200 3149500

3139400 2460100 3170255

3465500 2734000 3551798

3376900 2625200 3400240

3556300 2759900 3587877

3280400 2470300 3184464

3644300 2778600 3613926

3497400 2638400 3418627

3667700 2796400 3638721

3601100 2755400 3581608

3879100 2980900 3895730

Bristol Myers Squibb

cost of sales/ revenue

tota

l/net

revenue

2000000150000010000005000000

6000000

5500000

5000000

4500000

4000000

3500000

3000000

S 281661R-Sq 80.6%R-Sq(adj) 78.6%

Regression95% CI

Bristol Myer Squibb total/net revenue = 3466989 + 0.9945 cost of sales/revenue

Bristol Myers SquibbForecast

Forecast/ Cost of Sales

Re

ve

nu

e

55000005000000450000040000003500000

6000000

5500000

5000000

4500000

4000000

3500000

3000000

S 281661R-Sq 80.6%R-Sq(adj) 78.6%

Regression95% CI

Bristal Myers Squibbtotal/net revenue = - 1 + 1.000 Forecast Revenue COS Forecast

4728000 1709000 5166590

5129000 1852000 5308803

5372000 1929000 5385380

5665000 2102000 5557428

5181000 1483000 4941833

5430000 1483000 4941833

5427000 1595000 5053217

3342000 -105000 3362567

4532000 1367000 4826471

4889000 1483000 4941833

4767000 1483000 4941833

5019000 1595000 5053217